about
Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activitiesInhibition of gastric lipase as a mechanism for body weight and plasma lipids reduction in Zucker rats fed a rosemary extract rich in carnosic acidA rosemary extract rich in carnosic acid selectively modulates caecum microbiota and inhibits β-glucosidase activity, altering fiber and short chain fatty acids fecal excretion in lean and obese female ratsAddressing the inter-individual variation in response to consumption of plant food bioactives: Towards a better understanding of their role in healthy aging and cardiometabolic risk reduction.Gordonibacter urolithinfaciens sp. nov., a urolithin-producing bacterium isolated from the human gut.Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species.Development, validation and evaluation of an analytical method for the determination of monomeric and oligomeric procyanidins in apple extracts.Strawberry processing does not affect the production and urinary excretion of urolithins, ellagic acid metabolites, in humans.Evaluation of Pseudomonas aeruginosa (PAO1) adhesion to human alveolar epithelial cells A549 using SYTO 9 dye.Phenolic compounds and fatty acids from acorns (Quercus spp.), the main dietary constituent of free-ranged Iberian pigs.Safety evaluation of an oak-flavored milk powder containing ellagitannins upon oral administration in the rat.Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism.In vitro transformation of chlorogenic acid by human gut microbiota.The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells.Guidelines for Research on Bioactive Constituents--A Journal of Agricultural and Food Chemistry Perspective.The human gut microbial ecology associated with overweight and obesity determines ellagic acid metabolism.Targeted and Untargeted Metabolomics to Explore the Bioavailability of the Secoiridoids from a Seed/Fruit Extract (Fraxinus angustifolia Vahl) in Human Healthy Volunteers: A Preliminary Study.Metabolic and transcriptional elucidation of the carotenoid biosynthesis pathway in peel and flesh tissue of loquat fruit during on-tree development.Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery diseaseInteraction between phenolics and gut microbiota: role in human health.Ellagitannins, ellagic acid and vascular health.A rosemary extract enriched in carnosic acid improves circulating adipocytokines and modulates key metabolic sensors in lean Zucker rats: Critical and contrasting differences in the obese genotype.Dietary phenolics against colorectal cancer--From promising preclinical results to poor translation into clinical trials: Pitfalls and future needs.Neuroprotective Effects of Bioavailable Polyphenol-Derived Metabolites against Oxidative Stress-Induced Cytotoxicity in Human Neuroblastoma SH-SY5Y Cells.LC-MS Untargeted Metabolomics To Explain the Signal Metabolites Inducing Browning in Fresh-Cut Lettuce.Hesperetin and its sulfate and glucuronide metabolites inhibit TNF-α induced human aortic endothelial cell migration and decrease plasminogen activator inhibitor-1 (PAI-1) levels.Urolithins, the rescue of "old" metabolites to understand a "new" concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status.The ellagic acid derivative 4,4'-di-O-methylellagic acid efficiently inhibits colon cancer cell growth through a mechanism involving WNT16.Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells.Discovery of human urinary biomarkers of aronia-citrus juice intake by HPLC-q-TOF-based metabolomic approach.The gut microbiota: A key factor in the therapeutic effects of (poly)phenols.Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts.Interindividual Variability in Biomarkers of Cardiometabolic Health after Consumption of Major Plant-Food Bioactive Compounds and the Determinants Involved.A citrus extract containing flavanones represses plasminogen activator inhibitor-1 (PAI-1) expression and regulates multiple inflammatory, tissue repair, and fibrosis genes in human colon fibroblasts.In vivo relevant mixed urolithins and ellagic acid inhibit phenotypic and molecular colon cancer stem cell features: A new potentiality for ellagitannin metabolites against cancer.Determination of interglycosidic linkages in O-glycosyl flavones by high-performance liquid chromatography/photodiode-array detection coupled to electrospray ionization ion trap mass spectrometry. Its application to Tetragonula carbonaria honey fromValidated Method for the Characterization and Quantification of Extractable and Nonextractable Ellagitannins after Acid Hydrolysis in Pomegranate Fruits, Juices, and Extracts.Metabolic engineering to simultaneously activate anthocyanin and proanthocyanidin biosynthetic pathways in Nicotiana spp.Isolation of Human Intestinal Bacteria Capable of Producing the Bioactive Metabolite Isourolithin A from Ellagic Acid.Inhibition by chestnut honey of N-Acyl-L-homoserine lactones and biofilm formation in Erwinia carotovora, Yersinia enterocolitica, and Aeromonas hydrophila.
P50
Q28299558-622AE197-1654-401A-A688-FA099FA2E6F4Q28480599-5FB73EA1-D5E2-4EA5-920D-E2FBF361FDB3Q28537822-4BBEDA28-EF88-4F00-AA96-34AE5A8D0D4FQ30244987-0AC3BF6C-39DA-4DCD-8535-990C40B5CE35Q30803495-BC556E50-2FF0-4853-9752-84FE4A1DCBE4Q30829776-1608121C-6175-466D-9E45-3EC3938F0A7CQ33559475-3A86F7AB-E9EC-422A-ADA8-E3BE23A25DD8Q34086140-8EC0E838-8991-45D4-AD94-1929086E4DCCQ34215462-806D7BD5-3604-4B62-9190-67523A4526D1Q34266225-668B4AA0-B6FC-49FE-8355-17B58D29DB84Q34764847-E03935F1-961A-4AC2-AA79-80C07276FA8DQ34992930-F5BCF87D-6516-45D2-8CD2-76A8BBF0D218Q35097048-D9742C73-6B09-40B0-B6CC-0995DEBDA7FFQ35598535-FDAB1D69-C945-48E3-AFF2-970A9A97A025Q35763495-4B84FA06-AADE-4679-AD39-F617E8AE509DQ35849074-7EF28805-CA9B-4B38-8BBA-8E46AFA29C32Q35874439-B813B557-03E7-4E69-9312-D46B42B44F89Q36405670-023B0FFB-BC9A-4BC7-AD71-0C0A2FAB9701Q36563015-912BD1C4-A94D-4188-948D-A68FC4EE394DQ37542185-38B8A923-EBAB-4F3F-80E4-3D42E24CCDCAQ37788330-2EC0E5F6-1B2A-433A-8A36-A4CC4A1DDDEFQ38308829-BE3C92A0-8C4C-4BB6-84A4-7E43BF6E0216Q38360706-8F84C21C-D863-49E9-B425-C7376CF76858Q38718590-B37AD6C8-3360-470F-848A-11EB69F66A3FQ38785426-49904031-6BE9-4E8F-943D-0F55FD4114E3Q38828868-5B37D28A-532B-4D7E-9BED-4D1AB903CDDCQ38829534-523FFB21-7A22-4579-AD4B-2287B2706661Q38901430-AE472ECF-7C3C-485B-8B5D-12111F308DD7Q39090075-6446440A-DF78-4FD0-974F-3182C4C002D2Q39234322-4AC978BE-C22F-48D0-949A-4F376D9BA095Q39291959-7BEAD60A-9DE2-4CAD-BA1F-9950910C068AQ39371828-B1AEB0C5-8776-49C4-B46E-D1B0F4F362D9Q39436135-8F26F9B6-97A3-4767-9F49-D338ACC72088Q39804004-6926AC29-FED3-4233-87B8-4A8A8186A7CFQ39904723-46735EB4-07BB-4A4D-B0F0-CEE1567FCFFBQ40500602-FB3B2A56-67A5-49F2-BE84-4122B211DD08Q40754735-C64AB796-D251-4EB3-96B2-BDA0AADF7EE7Q41140465-A2E872DA-00C8-402B-BF43-045152C02E55Q41269505-B44987AD-0693-4722-84FB-74C2419CC37EQ41436502-1E37422D-5C22-4C1A-8576-62E72FCF4053
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francisco A Tomas-Barberan
@ast
Francisco A Tomas-Barberan
@en
Francisco A Tomas-Barberan
@es
Francisco A Tomas-Barberan
@nl
Francisco A Tomas-Barberan
@sl
type
label
Francisco A Tomas-Barberan
@ast
Francisco A Tomas-Barberan
@en
Francisco A Tomas-Barberan
@es
Francisco A Tomas-Barberan
@nl
Francisco A Tomas-Barberan
@sl
prefLabel
Francisco A Tomas-Barberan
@ast
Francisco A Tomas-Barberan
@en
Francisco A Tomas-Barberan
@es
Francisco A Tomas-Barberan
@nl
Francisco A Tomas-Barberan
@sl
P1053
D-6686-2011
P106
P1153
7006427969
P21
P31
P3829
P496
0000-0002-0790-1739